Total Serum Bilirubin within 3 Months of Hepatoportoenterostomy Predicts Short-Term Outcomes in Biliary Atresia

MLA

Benjamin L. Shneider, et al. “Total Serum Bilirubin within 3 Months of Hepatoportoenterostomy Predicts Short-Term Outcomes in Biliary Atresia.” The Journal of Pediatrics, vol. 170, Mar. 2016, p. 211–217.e2. EBSCOhost, https://doi.org/10.1016/j.jpeds.2015.11.058.

APA

Benjamin L. Shneider, John C. Magee, Saul J. Karpen, Elizabeth B. Rand, Michael R. Narkewicz, Lee M. Bass, Kathleen Schwarz, Peter F. Whitington, Jorge A. Bezerra, Nanda Kerkar, Barbara Haber, Philip Rosenthal, Yumirle P. Turmelle, Jean P. Molleston, Karen F. Murray, Vicky L. Ng, Kasper S. Wang, Rene Romero, Robert H. Squires, … Cathie Spino. (2016). Total Serum Bilirubin within 3 Months of Hepatoportoenterostomy Predicts Short-Term Outcomes in Biliary Atresia. The Journal of Pediatrics, 170, 211–217.e2. https://doi.org/10.1016/j.jpeds.2015.11.058

Chicago

Benjamin L. Shneider, John C. Magee, Saul J. Karpen, Elizabeth B. Rand, Michael R. Narkewicz, Lee M. Bass, Kathleen Schwarz, et al. 2016. “Total Serum Bilirubin within 3 Months of Hepatoportoenterostomy Predicts Short-Term Outcomes in Biliary Atresia.” The Journal of Pediatrics 170 (March): 211–217.e2. doi:10.1016/j.jpeds.2015.11.058.